Emmanuel T Akporiaye Selected Research

Emmanuel T Akporiaye Research Topics

Disease

23	Neoplasms (Cancer) 01/2019 - 04/2003
7	Neoplasm Metastasis (Metastasis) 03/2013 - 05/2006
7	Breast Neoplasms (Breast Cancer) 11/2011 - 01/2005
3	Carcinoma (Carcinomatosis) 09/2012 - 07/2004
2	Melanoma (Melanoma, Malignant) 04/2012 - 08/2004
1	Hepatocellular Carcinoma (Hepatoma) 09/2012
1	Lung Neoplasms (Lung Cancer) 07/2012
1	Ovarian Neoplasms (Ovarian Cancer) 04/2012
1	Cardiotoxicity 11/2011
1	Drug-Related Side Effects and Adverse Reactions 06/2009
1	Carcinogenesis 06/2009
1	Adenoma (Adenomas) 09/2007
1	Renal Cell Carcinoma (Grawitz Tumor) 12/2004

Drug/Important Bio-Agent (IBA)

10	Vitamin E FDA LinkGeneric 03/2013 - 07/2004
9	TeaIBA 03/2016 - 10/2006
8	AntigensIBA 03/2013 - 04/2003
6	VaccinesIBA 09/2007 - 04/2003
5	2,5,7,8- tetramethyl- 2R- (4R,8R,12- trimethyltridecyl)chroman- 6- yloxy acetic acidIBA 03/2013 - 10/2006
5	Succinic Acid (Succinate)IBA 09/2012 - 07/2004
4	Ether (Diethyl Ether)IBA 09/2012 - 01/2011
3	alpha-Tocopherol FDA Link 09/2012 - 10/2006
3	CytokinesIBA 04/2012 - 04/2003
2	EsterasesIBA 03/2013 - 10/2006
2	Tocopherols (Tocopherol)IBA 03/2013 - 01/2011
2	Pharmaceutical PreparationsIBA 09/2012 - 04/2012
2	Transforming Growth Factor beta (TGF-beta)IBA 06/2009 - 04/2003
2	Peptides (Polypeptides)IBA 09/2007 - 08/2004
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 09/2007 - 05/2006
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2006 - 01/2005
1	Immune Checkpoint InhibitorsIBA 01/2019
1	AntibodiesIBA 05/2015
1	Granzymes (Granzyme)IBA 05/2015
1	triphenylphosphoniumIBA 09/2012
1	Adenosine Triphosphate (ATP)IBA 09/2012
1	Neoplasm Antigens (Tumor Antigens)IBA 07/2012
1	Immunosuppressive Agents (Immunosuppressants)IBA 04/2012
1	Therapeutic UsesIBA 04/2012
1	Acetic Acid (Vinegar)FDA LinkGeneric 04/2012
1	LigandsIBA 11/2011
1	Trastuzumab (Herceptin)FDA Link 11/2011
1	AcidsIBA 01/2011
1	InterferonsIBA 01/2011
1	Transforming Growth Factor beta Receptors (TGF beta Receptors)IBA 06/2009
1	Phosphotransferases (Kinase)IBA 06/2009
1	OligodeoxyribonucleotidesIBA 09/2007
1	Celecoxib (Celebrex)FDA Link 05/2006
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2006
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 05/2006
1	Interleukin-4 (Interleukin 4)IBA 05/2006
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 02/2006
1	dioleoyl phosphatidylethanolamineIBA 12/2004
1	ammonium bromideIBA 12/2004
1	DNA (Deoxyribonucleic Acid)IBA 12/2004
1	Interleukin-2 (IL2)IBA 12/2004
1	LeuvectinIBA 12/2004
1	HLA-A*02:01 antigenIBA 08/2004
1	Cancer VaccinesIBA 07/2004
1	Monoclonal AntibodiesIBA 04/2003

Therapy/Procedure

9	Immunotherapy 01/2019 - 07/2004
7	Therapeutics 05/2015 - 05/2006
1	Drug Therapy (Chemotherapy) 11/2011
1	Treatment Delay 06/2009